SCHEMBL752361

SCHEMBL752361

O=P(O)(OCc1ccccc1)c1ccccc1

nearest known ligand 0.68

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 2/20 0.68
▸ CETP P11597 3/20 0.51
▸ SRC P12931 1/20 0.47
▸ PDPK1 O15530 2/20 0.47
▸ MTOR P42345 1/20 0.47
▸ ALPG P10696 1/20 0.47
▸ PTK2B Q14289 1/20 0.47
▸ CFTR P13569 1/20 0.47
▸ CA2 P00918 1/20 0.46
▸ CA4 P22748 1/20 0.46
▸ CA5A P35218 1/20 0.46
▸ FOLH1 Q04609 1/20 0.45
▸ ALDH1A1 P00352 4/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ NPC1 O15118 1/20 0.42
▸ RAB9A P51151 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15732278 0.81 CA2 (0.52) TSHRSRCCFTRCA2CA4
SCHEMBL51316 0.81 TSHR (1.00) TSHRCETPSRCPDPK1MTOR
SCHEMBL27908642 0.81 TSHR (1.00) TSHRCETPSRCPDPK1MTOR
SCHEMBL206610 0.81 TSHR (0.76) TSHRCETPSRCPDPK1MTOR
SCHEMBL6685550 0.81 TSHR (0.76) TSHRCETPSRCPDPK1MTOR
SCHEMBL27944202 0.81 TSHR (0.53) TSHRCETPSRCPDPK1MTOR
SCHEMBL11741728 0.79 TSHR (0.73) TSHRCETPSRCPDPK1MTOR
SCHEMBL11756554 0.79 TSHR (0.96) TSHRCETPSRCPDPK1MTOR
SCHEMBL9446520 0.79 TSHR (0.96) TSHRCETPSRCPDPK1MTOR
Ammonia Solution, Strong SCHEMBL17670045 0.79 TSHR (0.73) TSHRCETPSRCPDPK1MTOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 137 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12597441-B2 Magnetic recording medium including fatty ester and fatty acid ester Sony Group Corporation (JP) 2026-04-07 — — US disclosed
US-20260065932-A1 MAGNETIC RECORDING MEDIUM SONY GROUP CORP (JP) 2026-03-05 — — US disclosed
US-20250336418-A1 MAGNETIC RECORDING MEDIUM SONY GROUP CORP (JP) 2025-10-30 — — US disclosed
WO-2023189347-A1 MAGNETIC RECORDING MEDIUM ソニーグループ株式会社 2023-10-05 — — WO disclosed
WO-2023002657-A1 MAGNETIC RECORDING MEDIUM ソニーグループ株式会社 2023-01-26 — — WO disclosed
US-10096333-B2 Magnetic recording medium FUJIFILM CORPORATION (JP) 2018-10-09 — — US disclosed
US-20150380037-A1 MAGNETIC RECORDING MEDIUM FUJIFILM CORPORATION (JP) 2015-12-31 — — US disclosed
US-8604233-B2 Lubricant composition, magnetic recording medium, and novel polyether compound FUJIFILM CORPORATION (JP) 2013-12-10 — — US disclosed
US-8476372-B2 Polyester fiber and method for its production, and tire cord, tire, belt-reinforcing fiber material and belt comprising the polyester fiber TEIJIN FIBERS LIMITED (JP) 2013-07-02 — — US disclosed
EP-2258891-B1 POLYETHYLENE NAPHTHALATE FIBER AND PROCESS FOR PRODUCING THE POLYETHYLENE NAPHTHALATE FIBER TEIJIN FIBERS LTD (JP) 2012-12-12 — — EP disclosed
US-6623849-B2 Multilayer FUJI PHOTO FILM CO., LTD. (JP) 2003-09-23 — — US disclosed
US-20030143323-A1 Method for producing magnetic recording medium and magnetic recording medium FUJI PHOTO FILM CO., LTD. 2003-07-31 — — US disclosed
US-20030118870-A1 Magnetic recording medium FUJI PHOTO FILM CO., LTD. 2003-06-26 — — US disclosed
US-20020090535-A1 Magnetic recording medium FUJIFILM HOLDINGS CORPORATION (JP) 2002-07-11 — — US disclosed
EP-1207522-A1 Magnetic recording medium FUJI PHOTO FILM CO., LTD. (JP) 2002-05-22 — — EP disclosed
US-20020018914-A1 Magnetic recording medium FUJIFILM HOLDINGS CORPORATION (JP) 2002-02-14 — — US disclosed
EP-0871454-A4 — — 1998-11-25 — — EP disclosed
EP-0871454-A1 PHOSPHOROUS-CONTAINING CYSTEINE AND SERINE PROTEASE INHIBITORS CEPHALON, INC. (US) 1998-10-21 — — EP disclosed
US-5639732-A FOR TREATING NERVOUS SYSTEM DISORDERS OR AS ANTIINFLAMMATORY AGENT CEPHALON, INC. (US) 1997-06-17 — — US disclosed
WO-1997003679-A1 PHOSPHOROUS-CONTAINING CYSTEINE AND SERINE PROTEASE INHIBITORS CEPHALON, INC. (US) 1997-02-06 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12597441-B2 Magnetic recording medium including fatty ester and fatty acid ester ELOVL1, MEF2D, ELOVL3 TSHR 2565/4885CETP 85/4885SRC 4078/4885
US-20260065932-A1 MAGNETIC RECORDING MEDIUM RAB10, RAB29, RAB1A TSHR 509/4885CETP 3302/4885SRC 3081/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback